Adolfo Garcia-Sastre

This inventor holds 72 USPTO granted patents and 38 published patent applications, plus 8 CIPO patents and 18 EPO patents, primarily in Influenza Virus Vaccines (CPC class C12N). Top assignees: Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adolfo Garcia-Sastre. Retrieved from https://idiyas.com/inventor/adolfo-garcia-sastre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 72 (Patent Applications = 38)

% Patents Active = 91.7

CIPO Patents = 8 (Patent Applications = 24)

EPO Patents = 18 (Patent Applications = 50)

Average Co-Inventor Count = 3.3

ph-index = 19

Forward Citations = 1,353(Granted Patents)

Forward Citations (Not Self Cited) = 627(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

66 out of 538

Icahn School of Medicine at Mount Sinai

patents

5 out of 621

Memorial Sloan Kettering Cancer Center

patents

5 out of 281

St. Jude Children's Research Hospital

patents

4. 5 out of 1,217

United States of America, as Represented by the Secretary of Agriculture

patents

5. 3 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 1 out of 23

Medimmune Vaccines, Inc.

patents

7. 1 out of 1,498

Rutgers, The State University of New Jersey

patents

8. 1 out of 99

Sanford-Burnham Medical Research Institute

University of Kentucky Research Foundation

patents

12. 1 out of 2,663

University of Pennsylvania

patents

13. 1 out of 1,384

Washington University

patents

14. 3 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Influenza Virus

Vaccines

Antibodies

Rigosertib

RNA Virus

Newcastle Disease

Chimeric Viruses

Monoclonal Antibodies

Antiviral Compounds

Hemagglutinin

Recombinant Viruses

Infectious Diseases

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12685764 - Universal Influenza Vaccine Using Nucleoside-Modified mRNA (2026-07-21),

2. 12655408 - RECOMBINANT NEURAMINIDASE AND USES THEREOF (2026-06-16),

3. 12616671 - Use of rigosertib to treat RNA virus infections (2026-05-05),

4. 12552788 - IMDQ-PEG-CHOL adjuvant and uses thereof (2026-02-17),

5. 12545718 - ANTI-INFLUENZA B VIRUS NEURAMINIDASE ANTIBODIES AND USES THEREOF (2026-02-10),

6. 12391957 - Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV disease or human metapneumovirus disease (2025-08-19),

7. 12364746 - Mosaic influenza virus hemagglutinin polypeptides and uses thereof (2025-07-22),

8. 12233123 - Influenza virus hemagglutinin proteins and uses thereof (2025-02-25),

9. 12042534 - Newcastle disease viruses and uses thereof (2024-07-23),

10. 12030928 - Anti-influenza B virus neuraminidase antibodies and uses thereof (2024-07-09),

11. 11865173 - Influenza virus hemagglutinin proteins and uses thereof (2024-01-09),

12. 11266734 - Influenza virus hemagglutinin proteins and uses thereof (2022-03-08),

13. 11254733 - Anti-influenza B virus neuraminidase antibodies and uses thereof (2022-02-22),

14. 10736956 - Influenza virus vaccination regimens (2020-08-11),

15. 10583188 - Influenza virus vaccines and uses thereof (2020-03-10),

Title: Innovator Spotlight: Adolfo Garcia-Sastre

Introduction: Adolfo Garcia-Sastre, a prolific inventor based in New York, NY, has made significant contributions in the field of virology with an impressive portfolio of 62 patents. His expertise lies in developing groundbreaking technologies to combat influenza virus, showcasing his commitment to advancing public health through innovative solutions.

Latest Patents: Among his recent patents is the pioneering work on "Influenza virus hemagglutinin proteins and uses thereof." This invention revolves around chimeric hemagglutinin (HA) polypeptides designed to induce a robust immune response against the influenza virus. These patents also encompass methods for generating antibodies to the chimeric HA polypeptides, offering promising avenues for influenza research and vaccine development.

Career Highlights: Adolfo Garcia-Sastre has left a lasting impact through his affiliations with prestigious institutions such as the Icahn School of Medicine at Mount Sinai and the Mount Sinai School of Medicine of New York University. His tenure at these renowned establishments underscores his dedication to advancing scientific knowledge and fostering groundbreaking research in virology.

Collaborations: Throughout his career, Adolfo Garcia-Sastre has collaborated with esteemed professionals in the field, including prominent figures like Peter M Palese and Florian Krammer. These collaborations have not only enriched his research endeavors but also paved the way for innovative discoveries that have the potential to revolutionize the field of virology.

Conclusion: Adolfo Garcia-Sastre's relentless pursuit of innovation and his exceptional contributions to the field of virology exemplify his status as a pioneering inventor. His relentless quest for scientific excellence continues to inspire future generations of inventors and researchers to push the boundaries of knowledge and make a lasting impact on public health worldwide.

Profile summary based on public USPTO records.